Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

In recent years, substantial advances in T-cell immunosuppressive strategies and their translation to routine clinical practice have revolutionized management and outcomes in autoimmune disease and solid organ transplantation. More than 80 diseases have been considered to have an autoimmune etiology, such that autoimmune-associated morbidity and mortality rank as third highest in developed countries, after cardiovascular diseases and cancer. Solid organ transplantation has become the therapy of choice for many end-stage organ diseases. Short-term outcomes such as patient and allograft survival at 1 year, acute rejection rates, as well as time course of disease progression and symptom control have steadily improved. However, despite the use of newer immunosuppressive drug combinations, improvements in long-term allograft survival and complete resolution of autoimmunity remain elusive. In addition, the chronic use of nonspecifically targeted immunosuppressive drugs is associated with significant adverse effects and increased morbidity and mortality. In this article, we discuss the current clinical tools for immune suppression and attempts to induce long-term T-cell tolerance induction as well as much-needed future approaches to produce more short-acting, antigen-specific agents, which may optimize outcomes in the clinic.

Original publication

DOI

10.2217/imt.11.61

Type

Journal article

Journal

Immunotherapy

Publication Date

07/2011

Volume

3

Pages

853 - 870

Keywords

Autoimmune Diseases, Calcineurin Inhibitors, Cell Differentiation, Cell Proliferation, Cytokines, Hematopoietic Stem Cell Transplantation, Humans, Immunosuppression, Immunosuppressive Agents, Janus Kinase 3, Organ Transplantation, Piperidines, Protein Kinase C, Pyrimidines, Pyrroles, Quinazolines, Receptors, Cytokine, T-Lymphocytes, Transplantation Immunology, Transplantation Tolerance